URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Janet Casey

Concepts (246)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Otitis Media
23
2002
127
7.300
Why?
Anti-Bacterial Agents
26
2003
437
7.070
Why?
Pharyngitis
15
2000
93
5.630
Why?
Tonsillitis
13
2000
59
4.710
Why?
Streptococcus pyogenes
13
2003
102
4.680
Why?
Streptococcal Infections
14
2000
171
3.720
Why?
Penicillins
12
2000
90
3.420
Why?
Cephalosporins
9
2000
67
3.400
Why?
Pneumococcal Infections
9
2007
88
2.600
Why?
Streptococcus pneumoniae
13
2005
111
2.290
Why?
Haemophilus Infections
9
2009
76
1.610
Why?
Pneumococcal Vaccines
6
2005
71
1.600
Why?
Haemophilus influenzae
12
2005
132
1.530
Why?
Acute Disease
15
2002
586
1.530
Why?
Nasopharynx
6
2010
48
1.510
Why?
Whooping Cough
4
2003
41
1.480
Why?
Clinical Trials as Topic
7
2002
671
1.440
Why?
Infant
28
1997
2278
1.440
Why?
Child, Preschool
29
1996
2660
1.400
Why?
Amoxicillin
6
2003
39
1.180
Why?
Child
25
1997
4155
1.160
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
3
2005
27
1.130
Why?
Randomized Controlled Trials as Topic
7
2003
411
1.070
Why?
Severity of Illness Index
6
2002
922
1.040
Why?
Otitis Media with Effusion
4
2003
36
1.020
Why?
Humans
56
1994
36274
0.980
Why?
Azithromycin
2
2003
19
0.970
Why?
Antibodies, Bacterial
7
2005
192
0.950
Why?
Drug Resistance, Multiple, Bacterial
4
2004
24
0.920
Why?
Vaccines, Conjugate
4
2005
42
0.890
Why?
Physician's Practice Patterns
2
2003
243
0.880
Why?
Treatment Outcome
13
1997
2615
0.830
Why?
Communicable Diseases, Emerging
2
2007
8
0.790
Why?
Bacterial Infections
3
2003
130
0.740
Why?
Moraxellaceae Infections
1
2010
3
0.730
Why?
Prospective Studies
12
2003
1689
0.720
Why?
Bacterial Outer Membrane Proteins
4
2009
62
0.710
Why?
Microbial Sensitivity Tests
7
2003
170
0.690
Why?
Diagnostic Errors
1
2008
90
0.630
Why?
Adolescent
13
1997
4766
0.620
Why?
Bacterial Proteins
5
2007
375
0.620
Why?
Treatment Failure
5
2004
128
0.600
Why?
Ambulatory Care
1
2008
156
0.600
Why?
Leukocyte Count
2
2003
161
0.600
Why?
Hemolysin Proteins
1
2007
15
0.590
Why?
Drug Prescriptions
2
2003
42
0.590
Why?
Bordetella pertussis
2
2003
24
0.590
Why?
Patient Selection
1
2008
212
0.580
Why?
Drug Hypersensitivity
1
2007
37
0.570
Why?
Respiratory Tract Infections
2
2003
159
0.560
Why?
Haemophilus Vaccines
3
2009
61
0.530
Why?
Pertussis Vaccine
1
2005
34
0.510
Why?
Adult
12
1997
11351
0.490
Why?
Pediatrics
1
2008
391
0.470
Why?
Polymerase Chain Reaction
4
1994
596
0.460
Why?
Drug Administration Schedule
7
2000
366
0.460
Why?
Anti-Infective Agents
2
2002
75
0.450
Why?
Antigens, Bacterial
3
2011
92
0.440
Why?
Recurrence
5
2003
691
0.430
Why?
Fever
1
2003
111
0.420
Why?
Moraxella (Branhamella) catarrhalis
4
2005
12
0.420
Why?
Cephalexin
3
2003
12
0.410
Why?
Serotyping
4
2005
68
0.410
Why?
Immunologic Memory
3
2006
119
0.360
Why?
United States
4
2006
2688
0.350
Why?
Male
23
1996
19675
0.350
Why?
Meningococcal Vaccines
4
2005
24
0.350
Why?
Multilocus Sequence Typing
4
2010
11
0.340
Why?
beta-Lactamases
3
2005
30
0.330
Why?
Immunoglobulin G
5
2009
488
0.330
Why?
Female
21
1997
19838
0.330
Why?
Tympanic Membrane
2
2008
20
0.320
Why?
Bacterial Typing Techniques
4
2005
24
0.270
Why?
Placebos
2
2003
178
0.270
Why?
Penicillin V
2
2003
27
0.270
Why?
Cefadroxil
2
2003
10
0.260
Why?
Middle Ear Ventilation
2
2004
13
0.260
Why?
New York
4
2004
1305
0.250
Why?
Evidence-Based Medicine
2
2007
202
0.250
Why?
Retrospective Studies
4
2007
2267
0.250
Why?
Penicillin Resistance
2
2000
30
0.250
Why?
Ear, Middle
2
2010
16
0.240
Why?
Carrier State
2
2010
32
0.240
Why?
Cohort Studies
3
2003
969
0.240
Why?
Serum
2
2010
13
0.240
Why?
Diagnosis, Differential
3
2003
874
0.220
Why?
Receptors, Cell Surface
1
1994
203
0.220
Why?
Follow-Up Studies
4
2003
1855
0.220
Why?
Time Factors
3
2003
3182
0.210
Why?
Coinfection
1
2012
5
0.210
Why?
Diphtheria Toxoid
3
2005
34
0.210
Why?
Antibiosis
1
2011
2
0.200
Why?
ROC Curve
1
2011
126
0.190
Why?
Sensitivity and Specificity
2
2010
905
0.190
Why?
Conserved Sequence
1
2011
103
0.180
Why?
Polysaccharides, Bacterial
3
2004
103
0.180
Why?
Bacteria
1
2010
81
0.180
Why?
Intercellular Adhesion Molecule-1
1
2010
125
0.170
Why?
Epidemiologic Research Design
1
2008
3
0.170
Why?
Otoscopy
1
2008
5
0.170
Why?
Process Assessment (Health Care)
1
2008
13
0.170
Why?
Predictive Value of Tests
1
2011
606
0.160
Why?
Milk, Human
1
2009
81
0.160
Why?
Bias (Epidemiology)
1
2008
44
0.160
Why?
Drug Utilization
1
2008
48
0.160
Why?
Reproducibility of Results
2
2008
877
0.160
Why?
Meningococcal Infections
2
2005
13
0.160
Why?
Paracentesis
1
2008
8
0.160
Why?
Exudates and Transudates
1
2008
16
0.160
Why?
Double-Blind Method
2
2005
992
0.160
Why?
CD4-Positive T-Lymphocytes
1
2011
303
0.160
Why?
Infant, Newborn
3
2000
1844
0.160
Why?
B-Lymphocytes
1
2012
432
0.160
Why?
Molecular Epidemiology
1
2007
11
0.150
Why?
Mannosyltransferases
1
2007
1
0.150
Why?
Congenital Disorders of Glycosylation
1
2007
1
0.150
Why?
Outcome and Process Assessment (Health Care)
1
2008
85
0.150
Why?
Siblings
1
2007
36
0.150
Why?
Cephaloridine
1
2007
2
0.150
Why?
Cefamandole
1
2007
3
0.150
Why?
Immunoglobulin E
1
2007
51
0.140
Why?
Cross Reactions
1
2007
108
0.140
Why?
Safety
1
2007
101
0.140
Why?
Age Factors
2
2006
1128
0.140
Why?
Immunization, Secondary
1
2006
71
0.140
Why?
Breast Feeding
1
2009
183
0.140
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2006
64
0.140
Why?
Europe
1
2006
80
0.140
Why?
Acoustic Impedance Tests
1
2005
12
0.140
Why?
Phylogeny
3
2009
117
0.140
Why?
Macrolides
1
2005
18
0.130
Why?
Vaccines, Acellular
1
2005
4
0.130
Why?
Cost of Illness
1
2005
79
0.130
Why?
Neisseria meningitidis
1
2005
21
0.130
Why?
Outcome Assessment (Health Care)
2
2003
301
0.130
Why?
Odds Ratio
1
2006
315
0.130
Why?
Combined Modality Therapy
2
1997
486
0.120
Why?
Autoimmune Diseases of the Nervous System
1
2004
6
0.120
Why?
Gram-Positive Bacteria
1
2004
11
0.120
Why?
Behavioral Symptoms
1
2004
15
0.120
Why?
Gram-Negative Bacteria
1
2004
21
0.120
Why?
Health Care Costs
1
2005
113
0.120
Why?
Publication Bias
1
2004
8
0.120
Why?
Drug Therapy, Combination
1
2005
382
0.120
Why?
Sex Distribution
1
2004
160
0.120
Why?
Young Adult
1
2008
1059
0.120
Why?
Age Distribution
1
2004
221
0.120
Why?
RNA, Bacterial
1
2003
80
0.110
Why?
Antibodies, Monoclonal
1
2007
711
0.110
Why?
Practice Guidelines as Topic
1
2005
302
0.100
Why?
Sequence Homology, Nucleic Acid
2
1994
141
0.100
Why?
Incidence
1
2004
685
0.100
Why?
Risk Factors
2
2004
2345
0.100
Why?
Chronic Disease
1
2003
522
0.100
Why?
Cognition Disorders
1
2004
286
0.100
Why?
DNA Primers
2
1994
403
0.090
Why?
Dose-Response Relationship, Drug
1
2003
1117
0.090
Why?
DNA, Bacterial
2
2009
173
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
462
0.080
Why?
Base Sequence
2
1994
1683
0.080
Why?
Molecular Sequence Data
2
1994
1988
0.070
Why?
Extracorporeal Membrane Oxygenation
1
1996
22
0.070
Why?
Anemia, Sickle Cell
1
1996
47
0.070
Why?
Respiratory Insufficiency
1
1996
58
0.070
Why?
Bone Marrow Transplantation
1
1997
197
0.070
Why?
Hematopoietic Stem Cell Transplantation
1
1997
131
0.070
Why?
Respiratory Distress Syndrome, Adult
1
1996
75
0.060
Why?
Erabutoxins
1
1994
1
0.060
Why?
Snakes
1
1994
3
0.060
Why?
Neoplasm Recurrence, Local
1
1997
288
0.060
Why?
Receptors, Urokinase Plasminogen Activator
1
1994
9
0.060
Why?
Genomic Library
1
1994
14
0.060
Why?
Glycosylphosphatidylinositols
1
1994
9
0.060
Why?
Multigene Family
1
1994
80
0.060
Why?
Urokinase-Type Plasminogen Activator
1
1994
64
0.060
Why?
Brain Neoplasms
1
1997
281
0.060
Why?
Exons
1
1994
168
0.060
Why?
Sequence Homology, Amino Acid
1
1994
288
0.060
Why?
HeLa Cells
1
1994
296
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1997
429
0.060
Why?
Questionnaires
2
2004
1004
0.050
Why?
Disease Susceptibility
1
2011
79
0.050
Why?
Chinchilla
1
2011
8
0.050
Why?
Consensus
1
2011
14
0.050
Why?
Streptolysins
1
2011
12
0.050
Why?
Drug Resistance, Bacterial
1
2011
48
0.050
Why?
Interdisciplinary Communication
1
2011
40
0.050
Why?
Amino Acid Sequence
1
1994
1195
0.050
Why?
Immunoglobulin D
1
2010
10
0.050
Why?
Oropharynx
1
2010
11
0.050
Why?
Epitopes
1
2011
202
0.040
Why?
Sequence Analysis, DNA
1
2011
166
0.040
Why?
Mutation, Missense
1
2011
87
0.040
Why?
Lipoproteins
1
2010
98
0.040
Why?
Infant Formula
1
2009
12
0.040
Why?
Antibody Formation
1
2010
179
0.040
Why?
Observer Variation
1
2009
144
0.040
Why?
Medical Records
1
2009
124
0.040
Why?
Patient Participation
1
2009
73
0.040
Why?
Genes, Bacterial
1
2009
163
0.040
Why?
Delayed-Action Preparations
1
2008
44
0.040
Why?
Single-Blind Method
1
2008
116
0.040
Why?
Pain Measurement
1
2009
246
0.040
Why?
Muscle Hypotonia
1
2007
7
0.040
Why?
Genetic Complementation Test
1
2007
55
0.040
Why?
Blindness
1
2007
33
0.040
Why?
Glycosylation
1
2007
64
0.040
Why?
Sex Factors
1
2009
597
0.040
Why?
Heterozygote
1
2007
125
0.040
Why?
Antibody Affinity
1
2006
13
0.040
Why?
Blood Bactericidal Activity
1
2006
18
0.040
Why?
Chi-Square Distribution
1
2008
344
0.040
Why?
Diphtheria
1
2006
13
0.040
Why?
Tetanus
1
2006
17
0.040
Why?
Cross-Sectional Studies
1
2009
654
0.040
Why?
DNA Mutational Analysis
1
2007
189
0.040
Why?
Immunoglobulin A
1
2006
90
0.040
Why?
DNA, Complementary
1
2007
264
0.040
Why?
Tetanus Toxoid
1
2006
40
0.040
Why?
Carrier Proteins
1
2010
426
0.030
Why?
Seizures
1
2007
148
0.030
Why?
Animals
2
1994
16093
0.030
Why?
Risk Assessment
1
2009
884
0.030
Why?
Central Nervous System Viral Diseases
1
2004
4
0.030
Why?
Phenotype
1
2007
763
0.030
Why?
Child Welfare
1
2004
71
0.030
Why?
Mice
1
1994
6111
0.030
Why?
Psychomotor Performance
1
2004
164
0.030
Why?
Administration, Oral
1
2003
308
0.030
Why?
Neuropsychological Tests
1
2004
386
0.030
Why?
Multivariate Analysis
1
2004
541
0.030
Why?
Mutation
1
2007
1216
0.020
Why?
Streptococcus
1
2000
80
0.020
Why?
Pinealoma
1
1997
4
0.020
Why?
Busulfan
1
1997
13
0.020
Why?
Melphalan
1
1997
28
0.020
Why?
Ependymoma
1
1997
10
0.020
Why?
Medulloblastoma
1
1997
20
0.020
Why?
Fibrosarcoma
1
1997
33
0.020
Why?
Transplantation, Autologous
1
1997
144
0.020
Why?
Cyclophosphamide
1
1997
174
0.020
Why?
Glioblastoma
1
1997
63
0.020
Why?
Radiography, Thoracic
1
1996
62
0.020
Why?
Syndrome
1
1996
208
0.020
Why?
Oxygen Consumption
1
1996
204
0.020
Why?
African Continental Ancestry Group
1
1996
125
0.020
Why?

Visualizations


Casey's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department